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Abstract 
 
Background:  Exposure to “early life” adversity is known to predict DNA methylation (DNAm) 
patterns that may be related to psychiatric risk. However, few studies have investigated whether 
adversity has time-dependent effects based on the age at exposure.  
 
Methods:  Using a two-stage structured life course modeling approach (SLCMA), we tested the 
hypothesis that there are sensitive periods when adversity induced greater DNAm changes. We 
tested this hypothesis in relation to two alternatives: an accumulation hypothesis, in which the 
effect of adversity increases with the number of occasions exposed, regardless of timing, and a 
recency model, in which the effect of adversity is stronger for more proximal events. Data came 
from the Accessible Resource for Integrated Epigenomics Studies (ARIES), a subsample of 
mother-child pairs from the Avon Longitudinal Study of Parents and Children (ALSPAC; 
n=691-774).  
 
Results:  After covariate adjustment and multiple testing correction, we identified 38 CpG sites 
that were differentially methylated at age 7 following exposure to adversity. Most loci (n=35) 
were predicted by the timing of adversity, namely exposures before age 3. Neither the 
accumulation nor recency of the adversity explained considerable variability in DNAm.  A 
standard EWAS of lifetime exposure (vs. no exposure) failed to detect these associations.  
 
Conclusions:  The developmental timing of adversity explains more variability in DNAm than 
the accumulation or recency of exposure. Very early childhood appears to be a sensitive period 
when exposure to adversity predicts differential DNAm patterns.  Classification of individuals as 
exposed vs. unexposed to “early life” adversity may dilute observed effects.   
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Introduction 
 
Exposure to childhood adversity, including poverty (1), abuse (2, 3), family dysfunction 
(4, 5), and other stressors (6, 7), is a common and potent determinant of mental health across the 
lifespan, increasing risk of childhood- and adult-onset psychiatric disorders by at least two-fold 
(8-10). Although the biological mechanisms explaining this relationship are poorly understood, 
accumulating evidence suggests adversity may become programmed molecularly, leaving behind 
biological memories that persistently alter genome function and increase susceptibility to mental 
disorders.  Indeed, dozens of candidate gene and epigenome-wide association studies (EWAS) in 
both animals and humans have shown that early life adversity is associated with persistent 
alterations in the epigenome (11-15), including changes in DNA methylation (DNAm), which is 
the most studied epigenetic mechanism involving the addition of methyl groups to cytosines in 
the DNA sequence (16, 17).  These differential DNAm sites can alter gene expression, providing 
a mechanism by which gene by environment interactions affect biological responses (18). 
Recent evidence, particularly from animal studies, suggests that epigenetic programming 
may be developmentally time-sensitive and that there may be sensitive periods (19, 20) when 
adversity exposure is more likely to induce DNAm changes.  For instance, rodent experiments 
have demonstrated the existence of sensitive periods for different aspects of epigenetic regulation 
– from embryonic reprogramming to postnatal exposure leading to differences in epigenetic 
outcomes and gene expression (21-25).  Recent work in nonhuman primates also suggests that 
there are differential effects on DNAm based on whether adversity exposure, including maternal 
separation, occurred at birth versus later in development (26).  Yet, few human studies, whether 
candidate gene (16, 27-29) or EWAS (30-32), have examined the time-dependent effects of 
psychosocial adversity on DNAm; nearly all human epigenetic studies have instead focused on 
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the presence versus absence of exposure to “early life” adversity.  Thus, it is unknown whether 
there are age stages when adversity differentially affects DNAm, children are therefore more 
vulnerable, and prevention efforts could be most efficacious.  
This study aimed to address this limitation by using data from a prospective, birth cohort 
of children to test the hypothesis that there are sensitive periods associated with DNAm 
alterations following adversity exposure.  To test this hypothesis, we used a two-stage Structured 
Life Course Modeling Approach (SLCMA) (33, 34) to examine the effect of repeated exposure 
to seven types of childhood adversities across three developmental periods (in very early 
childhood, before age 3; early childhood, ages 3-5; and middle childhood, ages 6-7) on DNAm 
profiles at age 7.  Recognizing that alternative conceptual models have been proposed to explain 
the effects of adversity, we also used the SLCMA to determine whether the sensitive period 
model explained more variability in DNAm relative to two other theoretical models described in 
the life course epidemiology literature (35-37): (1) an accumulation model (38-40), in which the 
effect of adversity on DNAm increases with the number of occasions exposed, regardless of 
timing; and (2) a recency model (41), in which the effect of adversity on DNAm is stronger for 
more proximal events.  Finally, to evaluate the potential advantage of the SLCMA relative to the 
standard EWAS approach, which would ignore the timing or frequency of adversity, we 
examined the number of epigenome-wide significant loci identified by each approach and 
evaluated their degree of overlap.  
 
Methods and Materials 
Sample and Procedures 
Data came from the Avon Longitudinal Study of Parents and Children (ALSPAC), a 
population-based birth cohort (42-44). ALSPAC generated blood-based DNAm profiles at birth 
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and age 7 as part of the Accessible Resource for Integrated Epigenomics Studies (ARIES), a 
subsample of 1,018 mother-child pairs from the ALSPAC (45).  The ARIES mother-child pairs 
were randomly selected out of those with complete data across at least five waves of data 
collection (Supplemental Materials). 
 
Measures 
Exposure to Adversity 
We examined the effect of seven adversities shown previously to associate with 
epigenetic marks (46-48): (a) caregiver physical or emotional abuse (49-52); (b) sexual or 
physical abuse (by anyone) (49-52); (c) maternal psychopathology (53, 54); (d) one adult in the 
household (55); (e) family instability (56, 57); (f) financial stress/poverty (58, 59); and (g) 
neighborhood disadvantage/poverty (60).  These adversities were chosen because they capture 
experiences that deviate from a child’s expected social and physical environment (61).  Each 
adversity was measured via maternal report on at least four occasions at or before age 7 from a 
single item or psychometrically validated standardized measures.  Specific time periods of 
assessment varied across adversity type (Supplemental Materials).  For each adversity type, we 
generated three sets of encoded variables (Supplemental Materials): (a) a set of variables 
indicating presence of the adversity at a specific developmental stage versus absence of the 
adversity at that stage, to test the sensitive period hypothesis; (b) a single variable denoting the 
total number of time periods of exposure to a given adversity, to test the accumulation 
hypothesis; and (c) a single variable denoting the total number of developmental periods of 
exposure, with each exposure weighted by the age of the child during the measurement time 
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period, to test the recency hypothesis; this variable upweighted more recent exposures, allowing 
us to determine whether more recent exposures were more impactful.  
 
DNA Methylation   
DNAm was measured at 485,000 CpG dinucleotide sites across the genome using the 
Illumina Infinium Human Methylation 450k BeadChip microarray.  DNA for this assay was 
extracted from cord blood and peripheral blood leukocytes at age 7.  DNA methylation wet 
laboratory procedures, preprocessing analyses, and quality control were performed at the 
University of Bristol (Supplemental Materials and (45)). DNAm levels are expressed as a 
‘beta’ value (β-value), representing the proportion of cells methylated at each interrogated CpG 
site.   
Prior to analysis, raw methylation β-values, which are preferred over M-values due to 
their interpretability (62), were normalized (63) to remove or minimize the effects of variation 
due to technical artifacts.  To adjust for DNAm variation due to cell type heterogeneity in 
peripheral and cord blood samples, we estimated cell counts from DNAm profiles (64) and 
regressed out these estimates from the normalized β-values.  Additionally, to remove possible 
outliers, we winsorized the β-values at each CpG site, setting the bottom 5% and top 95% of 
values to the 5th and 95th quantile, respectively (65).  
 
Covariates 
To adjust for baseline socio-demographic differences in the cohort, all analyses 
additionally controlled for the following variables, measured at child birth (Supplemental 
Materials): child race/ethnicity; child birth weight; maternal age; number of previous 
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pregnancies; sustained maternal smoking during pregnancy; and parent social class (66).  
Justification for the inclusion of parent social class as a covariate along with alternative results 
from analyses that exclude social class as a covariate are presented in the Supplemental 
Materials.  
 
Data Analysis 
Our primary analyses involved comparing the three theoretical models using the 
SLCMA, which was originally developed by Mishra (68) and later extended by Smith (33, 34) to 
analyze repeated, binary exposure data across the life course (Supplemental Materials).  The 
major advantage of the SLCMA is that it provides an unbiased way to compare multiple 
competing theoretical models simultaneously and identify the most parsimonious explanation for 
the observed outcome variation. The SLCMA uses Least Angle Regression (LARS) (69) and an 
associated covariance test (70) to identify the single theoretical model (or potentially more than 
one model working in combination) that explains the most outcome variation (R2). Compared to 
other methods for structured life course analysis, LARS has greater statistical power (33) and 
does not over-inflate effect size estimates (69) or bias hypothesis tests (70).  The SLCMA has 
been used in several life course epidemiology studies (71, 72), including studies of other birth 
cohorts (73, 74).  The LARS procedure functions under the same assumptions as multiple linear 
regression.  
In the first stage, we entered the set of encoded variables described previously into the 
LARS variable selection procedure (69).  LARS identified the variable with the strongest 
association with the outcome, thus identifying whether the sensitive period, accumulation, or 
recency model was most supported by the data. Therefore, for each CpG site, seven unique 
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LARS models were selected, corresponding to each type of adversity.  For each selected model, 
we performed a covariance test of the null hypothesis that the variable selected is unassociated 
with the outcome.  With respect to multiple testing, the covariance test p-values are adjusted for 
the number of variables included in the LARS procedure, controlling the type I error rate for 
each adversity type and CpG site.  To adjust for confounding during the first stage, we regressed 
each encoded variable on the covariates and implemented LARS on the regression residuals (34).  
In the second stage, the theoretical model shown in the first stage to best fit the observed 
data for a specific type of adversity was then carried forward to a multivariate regression 
framework, where measures of effect were estimated.  Only models with a covariance test p-
value <1x10-7, the standard Bonferroni correction threshold for epigenome-wide statistical 
significance, were included in the second stage.  Positive effect estimates thus indicate elevated 
(hyper) methylation and negative effect estimates indicate decreased (hypo) methylation.  The 
same covariates were also included in the second stage.  We compared the distribution of 
theoretical models across the Bonferroni-significant CpG sites with an omnibus chi-squared test, 
which tested the null hypothesis that the theoretical models were likely to be represented among 
the significant results in proportion to the frequency in which they were tested. 
To evaluate the loss or gain of information when using a simpler versus more complex 
analytic approach, we also performed seven EWASs (one for each type of adversity) to evaluate 
the association between lifetime exposure to adversity (coded as ever versus never exposed) and 
DNAm across all CpG sites.  The EWAS results were then compared to the SLCMA to 
determine if the two approaches yielded similar or distinct conclusions regarding the number of 
significant loci detected. 
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We also performed sensitivity analyses to evaluate the fit of the LARS selection 
procedure, determine the degree of differential methylation present at birth, and control for 
genetic variation.  We examined the biological significance of the findings by: (a) examining the 
correlation in methylation between blood and brain tissue for the top CpG sites using an online 
database (75); (b) investigating enrichment of regulatory elements annotated to false discovery 
rate (FDR)-significant CpG sites; (c) performing a functional clustering analysis of all Gene 
Ontology (GO) terms for genes annotated to FDR-significant sites in DAVID 6.8 (76); and (d) 
assessing the selective constraint of these genes using the Exome Aggregation Consortium 
(ExAC) (77).  
 
Results 
Sample Characteristics and Distribution of Exposure to Adversity 
Demographic characteristics of the ARIES analytic sample are shown in Table S1 for the 
total sample and among children exposed to any adversity (n=650, 67%, experienced at least one 
adversity at some point in their lifetime).  Details on the prevalence and correlations of exposure 
across time are also reported in Figures 1 and S1 and Table S2.  Of note, differences in the 
prevalence of exposure across time are unlikely to affect model selection as all variables are 
automatically standardized by the LARS procedure. 
 
Model Comparison and Effect Estimation 
We identified 38 CpG sites (“top sites”) that were differentially methylated at age 7 
following exposure to adversity (p<1x10-7, Figure 2). Methylation at most sites (n=35) was 
related to the developmental timing of exposure to adversity, especially adversity during very 
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early childhood, meaning between birth and age 2 (Figure 3a).  In fact, exposure to adversity 
during very early childhood explained variability at more CpG sites (22 in total) than expected, 
while the accumulation and recency models were associated with fewer CpG sites than expected 
(1 and 2 CpG sites, respectively; 𝜒2=11.43, p=0.02).  
As shown in Table 1 and Figure 3a, neighborhood disadvantage was the type of 
adversity predicting the greatest number of genome-wide methylation differences (10 CpG sites), 
followed by financial stress (9 CpG sites), sexual or physical abuse (by anyone) and one adult in 
the household (5 CpG sites). Maternal psychopathology, caregiver physical or emotional abuse, 
and family instability were associated with differences at four, three, and two CpG sites, 
respectively.  
 Across all 38 top sites, exposure to adversity was typically associated with 
hypermethylation (73.7% positive beta coefficients; 𝜒2=8.53, p=0.004; Table 1). On average, 
exposure to adversity during a sensitive period was associated with a 2.5% difference in 
methylation level (beta) after controlling for all covariates (range 0.1–14.2%). For the two CpG 
sites associated with recency of exposure to financial stress, one additional adverse event was 
associated with a 0.3–0.4% increase in methylation per year of age at the event.  For the single 
site associated with accumulation of exposure, one additional adverse event was associated with 
a 0.5% decrease in methylation. Of these 38 CpG sites, 14 remained statistically significant after 
imposing a more stringent p-value threshold that accounted for the testing of seven types of 
adversity (p=1x10-7 / 7=1.43x10-8; Table 1). 
After relaxing the multiple testing correction threshold to a FDR q<0.05, there were 380 
CpG sites affected by exposure to adversity (Figure 3b; Table S3). As with the top 38 
Bonferroni-significant sites, methylation at 352 of the 380 FDR-significant sites was best 
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explained by sensitive period models (Figures 3b, Table S3). Exposure in very early childhood 
explained methylation variation at more CpG sites than expected from the background for 
neighborhood disadvantage (Figures S2). The effects of adversity type and timing on 
methylation were distributed throughout the genome (Figure S3). 
 
Exposed vs. Unexposed Analysis 
 Across the seven EWASs, which separately evaluated the effect of ever versus never 
exposed to each type of adversity on CpG site DNAm, only one statistically significant result 
emerged (Figure S4); this was for cg02431672, a locus located on chromosome 1 79kb away 
from the gene FAM183A and was associated with exposure to abuse (E=-0.005; p=1.77x10-8).   
Overall, there was very little overlap in identified CpG sites across the top SLCMA and 
EWAS results.  Most of the top 38 sites had effect estimates that were larger in the SLCMA 
compared to the EWAS (Figure 4).  There was also little overlap in findings across specific CpG 
sites.  For example, the cg02431672 locus, which was the top hit in the EWAS of abuse, did not 
emerge as a top hit in the SLCMA of abuse, failing to appear in the list of FDR significant loci 
(p=0.0138).  Similarly, the top CpG site in the SLCMA (cg19157140), which suggested a 
sensitive period at age 1.75 associated with the effects of neighborhood disadvantage, was non-
significant in the corresponding EWAS (E=0.001; p=0.0002; Figure 5).  These results suggest 
that the SLCMA allowed us to more effectively identify methylation differences among children 
with and without a history of exposure to adversity. 
 
Sensitivity Analyses 
Evaluation of the LARS Selection Procedure 
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There was no evidence in support of compound theoretical models, whereby more than 
one theoretical model explained the most outcome variability.  For each of the top 38 CpG sites, 
the marginal increase in variance of methylation explained by additional steps of the LARS 
procedure was not significant (each p>0.05, Figure S5), suggesting that methylation was best 
explained by a single theoretical model.  
 
Evaluation of Methylation at Birth for Top CpG Sites 
Adversity-associated methylation differences occurred during early childhood for most 
top CpG sites. After examining the effect of the selected exposure on DNAm in cord blood for 
the top 38 sites, we found that DNAm differences at birth were only significant for one out of the 
38 sites (p>0.05/38=0.00132), suggesting that the differences in DNAm at age 7 mainly occurred 
after birth, as a result of exposure to postnatal stressors (Table S4).  Similar results were 
obtained when examining the 380 FDR significant loci, where significant differences at birth 
were detected at only six out of the 380 probes (Table S4-Extension). An example of a site 
differentially methylated at birth and an example of a site non-differentially methylated at birth 
are shown in Figure S6. 
 
Correction for Genetic Variation 
 Genetic variation did not appear to influence observed DNAm differences at the top CpG 
sites. Using a database of methylation quantitative trait loci (mQTLs) of the ARIES cohort (78), 
there were 658 SNPs associated with DNAm at 17 of the top 38 sites. After controlling for 
genetic variation at mQTLs linked to these 17 sites, the effect of exposure to adversity remained 
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significant (each FDR q<0.05; Table S5), suggesting that adversity could have caused these 
methylation differences distinct from genetic sequence variation. 
 
Exploring the Biological Significance of Findings 
Correlation Between Blood and Brain Tissue 
On average, methylation in blood at the top 38 sites was slightly positively correlated 
with methylation in four brain regions (prefrontal cortex: ravg=0.10, entorhinal cortex: ravg=0.11, 
superior temporal gyrus: ravg=0.11, cerebellum: ravg=0.06; Table S6). CpG sites with methylation 
that is highly correlated between blood and brain tissue may be indicative of important inter-
individual covariation (i.e., because of adversity) or a strong genetic influence on methylation, 
while those that are uncorrelated may still be biomarkers of a response to adversity. 
 
Enrichment of Regulatory Elements 
As compared to all autosomal loci tested, FDR-significant loci were more likely to be 
located in gene promoters (𝜒2=9.92, p=0.002) and less likely to be in gene enhancers (𝜒2=3.86, 
p=0.049; Figure S7A). Furthermore, the location of FDR-significant loci differed from all other 
loci tested relative to CpG Islands (𝜒2=42.92, p<0.0001; Figure S7B).  With eFORGE 1.2 (79), 
we also tested whether FDR-significant loci colocalize with markers of transcriptional activity. 
FDR-significant loci were not enriched for DNase I hypersensitivity sites or histone marks in any 
tissue or cell-type after correction for multiple comparisons (each q>0.05). The strongest trend 
for enrichment was detected in the analysis of all histone marks in fetal thymus cells 
(uncorrected p=0.0007). Annotations at each FDR-significant site are presented in Table S3. 
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Biological Processes Potentially Affected by Adversity 
Genes near the FDR-significant sites (n=365 genes) corresponded to 158 clusters of GO 
biological process terms (76). The top 11 GO term clusters, including positive regulation of 
developmental growth, axon development, and neuron apoptotic process, were more likely to be 
represented than chance (average enrichment p<0.05; Figure S8).  
Additionally, we uncovered evidence of functional constraint for these genes. Genes 
annotated to FDR-significant sites were more highly constrained, as measured by the probability 
of intolerance to Loss-of-Function variation (pLI) from ExAC (77), than the rest of the 
autosomal genes tested (permutation p=0.0001; Figure S9). This indicates a greater importance 
of these genes, on average, to survival and reproduction over human evolution. 
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Discussion 
This prospective study used data from a large population-based sample of children to test 
three competing life course theoretical models describing the association between exposure to 
childhood adversity, measured repeatedly across the first 7 years of life, and DNAm at age 7.  By 
comparing these theoretical models to each other, we could evaluate which one explained the 
most variation in DNAm.  To our knowledge, this is the first use of the SLCMA in an 
epigenome-wide context.   
The main finding of this study is that the effect of adversity on DNAm depends primarily 
on the developmental timing of exposure.  In our Bonferroni-corrected analysis, we identified 38 
CpG sites that were differently methylated following exposure to adversity, with more than half 
of these loci showing associations based on adversity occurring during very early childhood, 
meaning before age 3.  Exposure in very early childhood was associated with DNAm differences 
for nearly all adversity types.  In contrast, the effects of exposure in middle childhood were 
largely only detected for arguably most severe forms of adversity exposure (e.g., sexual or 
physical abuse).  These results are consistent with at least one human longitudinal study (16) and 
multiple animal studies (21, 22, 24, 25) in emphasizing the existence of sensitive periods (19, 20) 
– particularly occurring shortly after birth – when epigenetic programming is maximally 
dynamic in response to parental care disruptions and other environmental inputs.  The lack of 
detectable sensitive periods in one recent study (32) may be due to focusing only on adversities 
occurring at or after age 5.  Interestingly, neither the accumulation nor recency of the adversity 
explained considerable variability in DNAm.  The observed DNAm differences were absent at 
birth, identified for a range of adversities, and unrelated to genetic variation.  The absence of 
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support for an accumulation model is surprising, given previous research linking cumulative time 
spent in institutional care to DNAm status in stress-related genes (29).   
Perhaps more importantly, our results suggest that broad classifications of individuals as 
exposed versus unexposed to “early life” adversity – although commonly used – may dilute 
observed effects and fail to detect DNAm differences among those exposed to adversity during 
specific life stages.  These findings support the value of more detailed phenotyping, which is 
meaningful given the trend in psychiatric genetics towards minimizing phenotypic precision in 
the service of maximizing sample size.  The lack of overlap in identified loci across the SLCMA 
and EWAS suggest that refinement of the environmental phenotype – by treating each time point 
of exposure as unique – may better capture underlying signal.  Indeed, results of a post-hoc 
power calculation suggest that the EWAS of exposed versus unexposed will be underpowered 
when the true underlying relationship between exposure and outcome depends on the timing or 
amount of exposure (Supplemental Materials).  Thus, more precise phenotyping could preserve 
study power and provide more mechanistic insights to guide targeted interventions.  
These findings also raise important questions regarding why exposure to adversity in the 
first three years of life may be particularly salient in influencing DNA methylation patterns.  
When adversity occurs early in life, it coincides with when the foundation of brain architecture is 
initially sculpted.  Experiences of childhood adversity, which represent deviations from expected 
cognitive, social, and sensory inputs (61), may be more likely to be wired into neural circuitry 
during this especially vulnerable stage in brain development.  Relatedly, DNAm patterns are 
known to be dynamic across the lifecourse.  It may be that very early exposure to adversity 
produces more stable DNAm changes that persist across the lifecourse, in contrast to later 
exposure to adversity.  With more longitudinal studies of DNAm, the field of psychiatric 
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epigenetics will be better positioned to determine not only when are the most vulnerable life 
stages for DNAm changes to occur, but also the extent to which these adversity-induced DNAm 
patterns persist over time. 
Although these findings emphasize the importance of exposure timing, greater insights 
are needed regarding the age stages when adversity may be most harmful, as mixed results have 
emerged among the small number of studies comparing the effects of “early” to “later” adversity.  
Some retrospective studies have shown that adolescent DNAm patterns are more strongly 
associated with life stress during adolescence than earlier periods (27).  However, other studies 
have found potentially persistent effects of childhood adversity into adolescence (80) and 
adulthood (81), even after accounting for subsequent stress exposure.  A recent study also found 
that the effects of adversity timing may be gene-specific (29).  As epigenetic patterns appear to 
vary over the life course (26, 82), longitudinal studies are needed to study the developmental 
trajectories of DNAm and evaluate the extent to which these adversity-induced DNAm 
differences persist or attenuate over time, and operate independently of or in interaction with 
subsequent experience to ultimately predict mental health outcomes.  Ideally, these longitudinal 
studies would include repeated measures of prenatal and postnatal adversity exposure and 
investigate whether any adversity-associated DNAm signatures predict psychopathology.  If our 
findings about the importance of sensitive periods do replicate, these results would emphasize 
the need to prioritize policies and interventions towards children exposed to adversity within the 
first three years of life, when the biological effects of adversity may be most profound.  
Several limitations are noted. First, some adversity measures were drawn from single 
items.  Parents may have also under-reported exposure to stigmatizing experiences (83, 84), 
especially if they were implicated in the exposure (85).  However, the prevalence of several 
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adversities, including those capturing possible experiences of abuse, were similar to and even 
greater than those reported from some nationally-representative samples (9, 86).  Second, as with 
any longitudinal study, there was attrition over time, which could result in bias due to loss of 
follow-up.  However, ARIES children were sampled from among those with the most complete 
longitudinal data.  Within the field of epigenetics, efforts are now underway to understand the 
consequences of attrition and how potential biases arising from attrition could be mitigated 
through multiple imputation or other strategies.  Third, we were unable to examine the impact of 
experiencing multiple adversities simultaneously because each adversity was measured at 
slightly different time points.  Fourth, the DNAm samples were obtained from peripheral tissue 
and not the brain; multiple datasets, however, are starting to identify limited though important 
shared DNAm patterns across central nervous system and peripheral tissue (87).  Fifth, we were 
unable to directly examine whether DNAm at the identified loci influenced gene expression of 
the nearest genes.  Future work using a sample with both methylation and expression data is 
needed to clarify the functional consequences of significant CpG sites.  Finally, the p-values 
derived from the covariance tests could be potentially inflated, as the test relies on asymptotic 
theories and therefore does not theoretically guarantee the control of Type I error rate in a finite 
sample (70).  However, the covariance test might be a more sensitive method to detect signals 
compared to other post-selection significance tests that make fewer assumptions (88).  As the 
relative statistical power of the available tests remains unclear, simulation studies are underway 
to identify the best inference tools in different settings and the statistical power of the SLCMA 
with varying effect sizes.   
In summary, this study lends further support to the evidence-base showing that DNAm 
patterns are responsive to experience.  However, these results reveal that DNAm patterns may be 
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most influenced by exposures during sensitive periods in development.    Efforts may therefore 
be needed to move beyond crude comparisons of those exposed versus unexposed to “early life” 
adversity.    
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Figure 1. Exposure to adversity in the ARIES dataset  
 
 
The figure displays the lifetime prevalence by age 7 of exposure to each adversity (labeled as 
total exposed), the average correlation between exposure to one type of adversity at one time 
point with exposure to that same adversity at a second time point (labeled as correlation over 
time), and the average correlation between exposure to one type of adversity and a second type 
of adversity (labeled as correlation with other adversities). Panel A: The lifetime prevalence of 
each adversity varied by type.  The most commonly reported adversities were financial stress 
(31%) and maternal psychopathology (29%).  The remaining adversities were less reported 
adversities, but still common: caregiver physical or emotional abuse (15%), neighborhood 
disadvantage (15%), sexual or physical abuse (by anyone; 13%), one adult in the household 
(13%), and family instability (11%).  Panel B: Among specific types of adversity, exposures 
tended to correlate over time, with neighboring time points being more related than distant time 
points. For instance, exposure to one adult in the household and neighborhood disadvantage were 
most strongly correlated over time (r=0.54–0.93 and r=0.67–0.89, respectively), whereas 
exposure to family instability (r=0.11–0.74) and sexual or physical abuse (r=0.02–0.69) were 
more weakly correlated across time. Panel C:  The average correlation of having ever been 
exposed to the other adversities was modest across adversities, suggesting that we were capturing 
unique subtypes of adversity.   
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Figure 2. Manhattan plot displaying top CpG sites associated with exposure to adversity 
 
In this Manhattan plot, the x-axis is the chromosomal position for each CpG site and the y-axis is 
the -log10 p-value for the association between exposure to adversity and DNAm values at each 
CpG site.  The dashed line shows the epigenome-wide significance level, with each CpG site 
above the line representing a statistically significant association (p<1x10-7).  The color of each 
CpG site refers to the type of adversity.  The shape of each CpG site indicates the lifecourse 
model tested.  The sensitive period hypotheses were encoded as circle: very early childhood, 
triangle: early childhood, square: middle childhood.  The recency hypothesis was encoded as a 
diamond.  As shown, CpG sites significantly affected by exposure adversity were distributed 
throughout the genome. There was no obvious genomic spatial pattern by adversity type or 
timing of exposure. 
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Figure 3. Frequency each lifecourse theoretical model was chosen for each type of adversity 
 
Each plot displays the number of CpG sites for which adversity significantly predicted 
methylation, after controlling for covariates and correcting for multiple comparisons using (a) a 
Bonferroni threshold (p<1x10-7, n=38 sites) and (b) a False Discovery Rate (FDR) correction q < 
0.05 (n=380 sites). The distribution of theoretical models chosen first by the LARS procedure for 
top CpG sites was significantly different than expected by chance, with exposure to adversity 
during sensitive periods, especially during very early childhood, more frequently predicting 
methylation. 
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Figure 4. Scatterplot displaying increased power in the SLCMA shown by the comparison of 
beta estimates from the EWAS vs. SLCMA approaches 
 
In this scatterplot, the y-axis represents the beta estimates associated with the 38 top CpG sites 
derived for the SLCMA; the x-axis represents the beta estimates associated with the same 38 
CpG sites obtained from EWAS. Different types of adversity are indicated by colors. The black 
straight line denotes the 1:1 correspondence between the two sets of beta values. Substantial 
positive deviation from the line suggests increased power in the SLCMA. For most CpG sites, 
the magnitudes of effect were larger for the SLCMA compared to the EWAS results. 
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Figure 5. Comparison of EWAS vs. SLCMA estimates for the top CpG site identified in 
SLCMA, cg19157140 
 
The effect estimates and the confidence intervals obtained from the EWAS approach comparing 
ever exposed to never exposed to financial stress for cg19157140 are presented on the left. The 
stage 2 effect estimates and confidence intervals obtained from the SLCMA comparing being 
exposed to neighborhood disadvantage at age 1.75 to being unexposed at age 1.75 for the same 
CpG site are displayed on the right. The top CpG site in the SLCMA, which suggested a 
sensitive period at age 1.75 associated with the effects of neighborhood disadvantage, was non-
significant after correction for multiple testing (p=0.0002) in the EWAS of neighborhood 
disadvantage. 
Table 1. Results of the Structured Lifecourse Modeling Approach (SLCMA) in ARIES, with annotation to the closest gene, for the Bonferroni-significant CpG sites (p<1x10-7). 
CpG site Adversity First hypothesis chosen by 
LARS procedure 
DNAm in 
unexposed 
group 
(beta) 
DNAm in 
exposed 
group (beta) 
Increases 
in R^2 
P Beta 
(effect 
estimate) 
SE Lower 
95% 
CI 
Upper 
95% 
CI 
Chr Coordinate 
(bp) 
Nearest 
gene 
Distance to 
nearest gene 
(bp) 
cg10713431 Caregiver 
physical or 
emotional abuse 
(N=719) 
middle childhood (age 6) 0.132 0.139 0.025 4.59E-08 0.008 0.0019 0.004 0.012 20 43933204 MATN4 0 
cg12023170a middle childhood (age 6) 0.074 0.086 0.038 3.17E-10* 0.013 0.0022 0.008 0.017 1 23751761 TCEA3 499 
cg19825600a,b middle childhood (age 6) 0.458 0.384 0.027 3.23E-08 -0.072 0.0158 -0.103 -0.041 2 3704501 ALLC 1283 
cg01370449 Sexual or 
physical abuse 
(by anyone) 
(N=703) 
very early childhood (age 2.5) 0.244 0.334 0.030 8.87E-08 0.083 0.0168 0.050 0.116 7 27183369 HOXA-AS3 0 
cg06430102 very early childhood (age 2.5) 0.926 0.862 0.037 1.69E-09* -0.058 0.0103 -0.078 -0.038 19 1151960 SBNO2 0 
cg19170021 early childhood (age 4.75) 0.734 0.827 0.028 6.41E-08 0.092 0.0209 0.051 0.134 17 79077169 BAIAP2 0 
cg05072819a early childhood (age 5.75) 0.040 0.053 0.030 3.49E-08 0.014 0.0027 0.009 0.019 3 20081367 KAT2B 155 
cg05936516 middle childhood (age 6.75) 0.128 0.153 0.031 7.47E-08 0.025 0.0048 0.016 0.035 5 114507066 TRIM36 0 
cg04583813 Maternal 
psychopathology 
(N=691) 
very early childhood (age 8 mo.) 0.900 0.878 0.031 6.57E-08 -0.023 0.0046 -0.032 -0.014 10 560323 DIP2C 0 
cg08171937 very early childhood (age 2.75) 0.016 0.017 0.034 2.33E-10* 0.001 0.0003 0.001 0.002 12 49454761 RHEBL1 3705 
cg10666628 very early childhood (age 2.75) 0.020 0.021 0.029 9.29E-08 0.002 0.0004 0.001 0.003 5 179050666 HNRNPH1 0 
cg17806989 early childhood (age 5) 0.981 0.975 0.032 8.16E-09* -0.006 0.0012 -0.009 -0.004 13 25338287 RNF17 12 
cg08337366a One adult in the 
household 
(N=710) 
very early childhood (age 8 mo.) 0.934 0.906 0.029 6.07E-08 -0.032 0.0066 -0.045 -0.019 19 6371622 ALKBH7 820 
cg10192047 very early childhood (age 8 mo.) 0.016 0.019 0.029 1.31E-08* 0.003 0.0007 0.002 0.005 19 18722754 TMEM59L 926 
cg26990406 very early childhood (age 8 mo.) 0.868 0.728 0.027 7.22E-08 -0.142 0.0308 -0.203 -0.082 7 178829 FAM20C 14138 
cg24468070 very early childhood (age 1.75) 0.038 0.058 0.034 3.63E-10* 0.023 0.0044 0.014 0.031 19 54976501 CDC42EP5 0 
cg03397307 very early childhood (age 2.75) 0.025 0.030 0.030 8.46E-09* 0.005 0.0010 0.003 0.007 12 3862423 CRACR2A 56 
cg18311384 Family 
instability 
(N=703) 
very early childhood (age 2.5) 0.019 0.022 0.027 7.97E-08 0.002 0.0005 0.001 0.003 17 34842312 ZNHIT3 159 
cg27637303 very early childhood (age 2.5) 0.345 0.420 0.028 5.32E-08 0.078 0.0168 0.045 0.111 2 118942893 INSIG2 75295 
cg11631610 Financial stress 
(N=774) 
very early childhood (age 8 mo.) 0.949 0.923 0.027 1.20E-08* -0.027 0.0057 -0.038 -0.016 19 11322739 DOCK6 0 
cg06783003 very early childhood (age 1.75) 0.860 0.893 0.024 6.25E-08 0.037 0.0083 0.021 0.053 1 45116008 RNF220 0 
cg01050704a early childhood (age 5) 0.017 0.019 0.025 4.68E-08 0.002 0.0005 0.001 0.003 19 59084995 MZF1-AS1 0 
cg02006977 early childhood (age 5) 0.015 0.017 0.024 6.87E-08 0.002 0.0005 0.001 0.003 12 69139955 SLC35E3 0 
cg21299458 early childhood (age 5) 0.110 0.147 0.035 3.19E-11* 0.038 0.0070 0.024 0.052 22 20779896 SCARF2 0 
cg19219503 middle childhood (age 7) 0.922 0.889 0.031 2.28E-10* -0.035 0.0071 -0.049 -0.021 10 37414802 ANKRD30A 0 
cg11714846 accumulation 0.923 0.915 0.023 6.64E-08 -0.005 0.0011 -0.007 -0.003 1 230419534 GALNT2 1658 
cg21924472 recency 0.756 0.770 0.027 1.87E-08 0.003 0.0006 0.002 0.004 4 139600734 LINC00499 255235 
cg24996440 recency 0.566 0.585 0.026 2.28E-08 0.004 0.0009 0.003 0.006 2 3583570 RNASEH1 9119 
cg00928478 Neighborhood 
disadvantage 
(N=702) 
very early childhood (age 1.75) 0.020 0.018 0.027 2.19E-08 -0.002 0.0005 -0.003 -0.001 10 99078824 FRAT1 196 
cg01954337 very early childhood (age 1.75) 0.050 0.059 0.028 5.32E-08 0.008 0.0018 0.005 0.012 11 3819010 NUP98 0 
cg04996689 very early childhood (age 1.75) 0.029 0.035 0.028 2.63E-08 0.006 0.0011 0.003 0.008 5 52285560 ITGA2 0 
cg12069925 very early childhood (age 1.75) 0.042 0.048 0.030 4.72E-09* 0.007 0.0014 0.004 0.009 17 11900858 ZNF18 72 
cg14522055 very early childhood (age 1.75) 0.030 0.035 0.028 6.77E-08 0.005 0.0011 0.003 0.007 15 64338757 DAPK2 235 
cg19157140 very early childhood (age 1.75) 0.014 0.016 0.037 2.87E-11* 0.002 0.0005 0.001 0.003 7 766323 PRKAR1B 0 
cg21740964 very early childhood (age 1.75) 0.160 0.173 0.025 7.13E-08 0.014 0.0028 0.008 0.019 6 3849331 FAM50B 299 
cg24826892a very early childhood (age 1.75) 0.016 0.018 0.030 5.50E-09* 0.003 0.0006 0.002 0.004 11 71159390 DHCR7 0 
cg08546016 early childhood (age 5) 0.050 0.056 0.029 3.63E-09* 0.006 0.0012 0.004 0.009 17 72776238 TMEM104 0 
cg12412390 middle childhood (age 7) 0.038 0.046 0.030 9.59E-08 0.008 0.0016 0.005 0.011 4 96469286 UNC5C 0 
DNAm = unadjusted DNA methylation (beta values) averaged within group; Increase in R2 = increase in R2 explained by first hypothesis chosen after accounting for covariates; P = p-value of covariance test assessing significance of increase 
in R2 explained; Beta, SE, Lower 95% CI, Upper 95% CI = parameter estimate, standard error, and lower and upper limits of 95% confidence interval of regression coefficient of first hypothesis chosen; Chr, Coordinate = chromosome and 
position of CpG site; Nearest gene, Distance to nearest gene = Gene symbol of and distance in bases to nearest gene from CpG site (as measured from transcription start site) 
a In potentially noisy probe list of Naeem et al. 2014 (i.e., cross-reactive probes, probes with SNPs/INDELs/repeat regions, probes affected by unknown factors)   
bIn potentially noisy probe list of Chen et al. 2013 (i.e., cross-reactive probes, probes with SNPs) 
*significant at p < 1.43x10-8 , a more stringent p-value threshold that accounted for the testing of seven types of adversity (1x10-7 / 7=1.43x10-8) 
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